Study · verified by the research team
Ashwagandha-induced liver injury — A case series from India and literature review
Philips CA, Valsan A, Theruvath AH, et al. (Liver Research Club India) · 2023 · Hepatology Communications 7(10): e0270
https://doi.org/10.1097/HC9.0000000000000270
Indian case series of single-ingredient ashwagandha liver injury, including deaths in patients with pre-existing liver disease.
Study details
| Design | Case series + literature review |
|---|---|
| Population | 8 patients with single-ingredient ashwagandha HILI (of 23 ashwagandha cases, 2019–2022) |
| Outcome | Liver injury and outcome |
| Finding | Mostly cholestatic hepatitis; 3 patients with underlying chronic liver disease developed acute-on-chronic liver failure and died; products free of contaminants |
| Limitations | Single centre network; case series |
| Certainty | low |